Marinus Pharmaceuticals reported $-16626000 in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -112.5M 68.38M
ALKERMES ALKS:US $ -7.39M 30.91M
Amgen AMGN:US $ 3341M 185M
Aptinyx Inc APTX:US $ -19279000 207K
Biogen BIIB:US $ 674.7M 20.2M
Eisai 4523:JP Y -11598M 35133M
Enanta Pharmaceuticals ENTA:US $ -33.02M 3.4M
Esperion Therapeutics ESPR:US $ -42836000 611K
Gilead Sciences GILD:US $ 3422M 1947M
Intercept Pharmaceuticals ICPT:US $ -9.9M 10.55M
Intra Cellular Therapies ITCI:US $ -72.49M 13.37M
Marinus Pharmaceuticals MRNS:US $ -16.63M 10.4M
Minerva Neurosciences NERV:US $ -7.99M 13.39M
Neurocrine Biosciences NBIX:US $ 6.4M 60.6M
Ptc Therapeutics PTCT:US $ -60.21M 5.71M
Regeneron Pharmaceuticals REGN:US $ 1360.9M 1353.3M
Sarepta Therapeutics SRPT:US $ -76.16M 19.51M
Supernus Pharmaceuticals SUPN:US $ 23.33M 17.79M
Vertex Pharmaceuticals VRTX:US $ 1069.3M 159.74M
YTE INCY:US $ 144.1M 9.29M